Bhageria Industries Ltd Company Analysis

Bhageria Industries is a diversified business with its core operations in specialty chemicals, particularly dye and pigment intermediates, alongside solar power generation and a developing pharmaceutical business. The chemicals segment is currently the main earnings driver, supported by expanded H-Acid capacity from 400 to 500 tonnes per month and the commencement of plasticizer production at Tarapur. FY26 showed a substantial improvement, with consolidated revenue from operations reaching about ₹874 crore versus ₹597 crore in FY25. Chemical-segment revenue increased to about ₹830 crore from ₹504 crore, while the solar segment remained relatively stable at ₹26.9 crore. Q1 FY27 continued this momentum, with consolidated revenue of ₹286.4 crore, up 81.9% YoY, and PAT of ₹33.9 crore, up 210.7%. EBITDA increased to ₹57.6 crore, with operating margin improving sharply to 20.1% from 15.4% in Q1 FY26. The major growth opportunity lies in scaling H-Acid and plasticizer capacity, improving export volumes and expanding the solar portfolio. The company commissioned additional solar capacity during FY26 and added another 7 MW in May 2026, taking installed solar capacity to 21 MW. At around ₹352 as of 24 September 2026, the stock was valued at approximately ₹1,528 crore market capitalisation, with P/E around 22.6x, ROE 7.7% and debt-to-equity around 0.17x. Key risks include specialty-chemical cyclicality, raw-material and export-market volatility, relatively modest return ratios, working-capital requirements and execution risk in new capacity. The recent earnings acceleration is significant, but sustaining margins and converting capacity expansion into consistent cash generation will be important to monitor.